{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T01:03:38Z","timestamp":1784077418554,"version":"3.55.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ophthal Inflamm Infect"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Ocular toxoplasmosis is a leading cause of vision impairment and is burdened by the risk of recurrence. This study, conducted at the University Hospital of Verona, aimed to identify potential risk factors associated with disease recurrence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main Body<\/jats:title>\n                    <jats:p>A total of 86 patients were treated for ocular toxoplasmosis between 1996 and 2023, with 43 completing treatment and follow-up of at least 18 months after treatment. Patients were treated with one of two therapeutic options: either trimethoprim-sulfamethoxazole or pyrimethamine-sulfametopyrazine. Over the study period, 21 patients experienced at least one recurrence, with a median time for the first recurrence of approximately six years. The average follow-up duration was eight years, and the probability of recurrence after seven years was 58%. Sleep duration emerged as a significant risk factor, as patients who slept between six and eight hours per night had a lower likelihood of recurrence. No significant associations were found with other factors, including gender, ethnicity, country of birth, education level, smoking, alcohol consumption, age at diagnosis, autoimmune diseases, vitamin deficiencies, vaccinations, cat ownership, consumption of raw or undercooked meat, place of residence, occupational soil exposure, primary infection (IgM positive), or the affected eye\u2019s laterality. Moderate evidence suggested a potential link between recurrences and psychological factors, such as stressful life events, lesion location, and pregnancy following the first diagnosis. Notably, women who experienced pregnancy after diagnosis had a threefold increased risk of recurrence. Regarding visual outcomes, there was modest evidence indicating that patients treated with trimethoprim-sulfamethoxazole achieved better final visual acuity compared to those treated with pyrimethamine. However, this difference was not statistically significant, and the underlying mechanism remains unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The findings highlight the potential role of sleep duration in reducing recurrence risk and suggest a possible association between psychological stress, post-diagnosis pregnancy, and recurrence. Additionally, trimethoprim-sulfamethoxazole treatment may contribute to better long-term visual acuity, although further research is needed to confirm these observations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12348-026-00578-x","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T16:16:12Z","timestamp":1779380172000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparison of risk factors and different therapeutic options for ocular toxoplasmosis recurrence: a retrospective study"],"prefix":"10.1186","volume":"16","author":[{"given":"Clara","family":"Rizzo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocco","family":"Micciolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Bacherini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Giansanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Bonacci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Marchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"Pedrotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Bosello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,21]]},"reference":[{"key":"578_CR1","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s10792-021-01994-9","volume":"42","author":"D Kalogeropoulos","year":"2022","unstructured":"Kalogeropoulos D, Sakkas H, Mohammed B et al (2022) Ocular toxoplasmosis: a review of the current diagnostic and therapeutic approaches. Int Ophthalmol 42:295\u2013321. https:\/\/doi.org\/10.1007\/s10792-021-01994-9","journal-title":"Int Ophthalmol"},{"key":"578_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000449169","volume":"57","author":"C Ozgonul","year":"2017","unstructured":"Ozgonul C, Besirli CG (2017) Recent developments in the diagnosis and treatment of ocular toxoplasmosis. Ophthalmic Res 57:1\u201312. https:\/\/doi.org\/10.1159\/000449169","journal-title":"Ophthalmic Res"},{"key":"578_CR3","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1128\/CMR.05013-11","volume":"25","author":"F Robert-Gangneux","year":"2012","unstructured":"Robert-Gangneux F, Dard\u00e9 M-L (2012) Epidemiology of and Diagnostic Strategies for Toxoplasmosis. Clin Microbiol Rev 25:264\u2013296. https:\/\/doi.org\/10.1128\/CMR.05013-11","journal-title":"Clin Microbiol Rev"},{"key":"578_CR4","first-page":"235689","volume":"4","author":"NA Saffra","year":"2013","unstructured":"Saffra NA, Seidman CJ, Weiss LM (2013) Ocular Toxoplasmosis: Controversies in Primary and Secondary Prevention. J Neuroinfect Dis 4:235689","journal-title":"J Neuroinfect Dis"},{"key":"578_CR5","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/s0161-6420(02)00990-9","volume":"109","author":"LEH Bosch-Driessen","year":"2002","unstructured":"Bosch-Driessen LEH, Berendschot TTJM, Ongkosuwito JV, Rothova A (2002) Ocular toxoplasmosis: clinical features and prognosis of 154 patients. Ophthalmology 109:869\u2013878. https:\/\/doi.org\/10.1016\/s0161-6420(02)00990-9","journal-title":"Ophthalmology"},{"key":"578_CR6","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/S0002-9394(99)00271-8","volume":"128","author":"EH Bosch-Driessen","year":"1999","unstructured":"Bosch-Driessen EH, Rothova A (1999) Recurrent ocular disease in postnatally acquired toxoplasmosis. Am J Ophthalmol 128:421\u2013425. https:\/\/doi.org\/10.1016\/S0002-9394(99)00271-8","journal-title":"Am J Ophthalmol"},{"key":"578_CR7","doi-asserted-by":"publisher","unstructured":"Holland GN, Crespi CM, N ten Dam-van Loon et al (2008) Analysis of recurrence patterns associated with toxoplasmic retinochoroiditis. Am J Ophthalmol 145:1007\u20131013. https:\/\/doi.org\/10.1016\/j.ajo.2008.01.023","DOI":"10.1016\/j.ajo.2008.01.023"},{"key":"578_CR8","doi-asserted-by":"publisher","first-page":"e0004892","DOI":"10.1371\/journal.pntd.0004892","volume":"10","author":"PK Borkowski","year":"2016","unstructured":"Borkowski PK, Brydak-Godowska J, Basiak W et al (2016) The impact of short-term, intensive antifolate treatment (with Pyrimethamine and Sulfadoxine) and antibiotics followed by long-term, secondary antifolate prophylaxis on the rate of toxoplasmic retinochoroiditis recurrence. PLoS Negl Trop Dis 10:e0004892. https:\/\/doi.org\/10.1371\/journal.pntd.0004892","journal-title":"PLoS Negl Trop Dis"},{"key":"578_CR9","doi-asserted-by":"publisher","unstructured":"Pradhan E, Bhandari S, Gilbert RE, Stanford M (2016) Antibiotics versus no treatment for toxoplasma retinochoroiditis. Cochrane Database Syst Rev 2016:CD002218. https:\/\/doi.org\/10.1002\/14651858.CD002218.pub2","DOI":"10.1002\/14651858.CD002218.pub2"},{"key":"578_CR10","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1080\/09273948.2022.2117705","volume":"31","author":"EJH Goh","year":"2023","unstructured":"Goh EJH, Putera I, La Distia Nora R et al (2023) Ocular Toxoplasmosis. Ocul Immunol Inflamm 31:1342\u20131361. https:\/\/doi.org\/10.1080\/09273948.2022.2117705","journal-title":"Ocul Immunol Inflamm"},{"key":"578_CR11","doi-asserted-by":"publisher","unstructured":"Aleixo ALQ do C, Vasconcelos C de Oliveira R, Cavalcanti Albuquerque M, et al (2019) Toxoplasmic retinochoroiditis: The influence of age, number of retinochoroidal lesions and genetic polymorphism for IFN-\u03b3\u2009+\u2009874 T\/A as risk factors for recurrence in a survival analysis. PLoS One 14:e0211627. https:\/\/doi.org\/10.1371\/journal.pone.0211627","DOI":"10.1371\/journal.pone.0211627"},{"key":"578_CR12","doi-asserted-by":"publisher","first-page":"e0283845","DOI":"10.1371\/journal.pone.0283845","volume":"18","author":"C Cifuentes-Gonz\u00e1lez","year":"2023","unstructured":"Cifuentes-Gonz\u00e1lez C, Rojas-Carabali W, P\u00e9rez \u00c1O et al (2023) Risk factors for recurrences and visual impairment in patients with ocular toxoplasmosis: A systematic review and meta-analysis. PLoS ONE 18:e0283845. https:\/\/doi.org\/10.1371\/journal.pone.0283845","journal-title":"PLoS ONE"},{"key":"578_CR13","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/s0002-9394(02)01527-1","volume":"134","author":"C Silveira","year":"2002","unstructured":"Silveira C, Belfort R, Muccioli C et al (2002) The effect of long-term intermittent trimethoprim\/sulfamethoxazole treatment on recurrences of toxoplasmic retinochoroiditis. Am J Ophthalmol 134:41\u201346. https:\/\/doi.org\/10.1016\/s0002-9394(02)01527-1","journal-title":"Am J Ophthalmol"},{"key":"578_CR14","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1136\/bjophthalmol-2019-315522","volume":"105","author":"S Ajamil-Rodanes","year":"2021","unstructured":"Ajamil-Rodanes S, Luis J, Bourkiza R et al (2021) Ocular toxoplasmosis: phenotype differences between toxoplasma IgM positive and IgM negative patients in a large cohort. Br J Ophthalmol 105:210\u2013215. https:\/\/doi.org\/10.1136\/bjophthalmol-2019-315522","journal-title":"Br J Ophthalmol"},{"key":"578_CR15","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"EL Kaplan","year":"1958","unstructured":"Kaplan EL, Meier P (1958) Nonparametric Estimation from Incomplete Observations. J Am Stat Assoc 53:457\u2013481. https:\/\/doi.org\/10.1080\/01621459.1958.10501452","journal-title":"J Am Stat Assoc"},{"key":"578_CR16","first-page":"163","volume":"50","author":"N Mantel","year":"1966","unstructured":"Mantel N (1966) Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50:163\u2013170","journal-title":"Cancer Chemother Rep"},{"key":"578_CR17","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","volume":"34","author":"DR Cox","year":"1972","unstructured":"Cox DR (1972) Regression Models and Life-Tables. J Roy Stat Soc: Ser B (Methodol) 34:187\u2013202. https:\/\/doi.org\/10.1111\/j.2517-6161.1972.tb00899.x","journal-title":"J Roy Stat Soc: Ser B (Methodol)"},{"key":"578_CR18","unstructured":"Breslow NE, Day NE (1987) Statistical methods in cancer research. II\u2013The design and analysis of cohort studies. IARC Sci Publ 1\u2013406"},{"key":"578_CR19","unstructured":"Team RC (2022) R: a language and environment for statistical computing (Version 4.2.0) [Computer software]"},{"key":"578_CR20","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.ajo.2018.11.013","volume":"199","author":"A Matet","year":"2019","unstructured":"Matet A, Paris L, Fardeau C et al (2019) Clinical and Biological Factors Associated With Recurrences of Severe Toxoplasmic Retinochoroiditis Confirmed by Aqueous Humor Analysis. Am J Ophthalmol 199:82\u201393. https:\/\/doi.org\/10.1016\/j.ajo.2018.11.013","journal-title":"Am J Ophthalmol"},{"key":"578_CR21","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1017\/S0950268813002756","volume":"142","author":"F Nogareda","year":"2014","unstructured":"Nogareda F, Le Strat Y, Villena I et al (2014) Incidence and prevalence of Toxoplasma gondii infection in women in France, 1980\u20132020: model-based estimation. Epidemiol Infect 142:1661\u20131670. https:\/\/doi.org\/10.1017\/S0950268813002756","journal-title":"Epidemiol Infect"},{"key":"578_CR22","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1093\/ije\/29.5.941","volume":"29","author":"EC Neto","year":"2000","unstructured":"Neto EC, Anele E, Rubim R et al (2000) High prevalence of congenital toxoplasmosis in Brazil estimated in a 3-year prospective neonatal screening study. Int J Epidemiol 29:941\u2013947. https:\/\/doi.org\/10.1093\/ije\/29.5.941","journal-title":"Int J Epidemiol"},{"key":"578_CR23","doi-asserted-by":"publisher","first-page":"e2541","DOI":"10.1371\/journal.pntd.0002541","volume":"7","author":"A de-la-Torre","year":"2013","unstructured":"de-la-Torre A, Sauer A, Pfaff AW et al (2013) Severe South American Ocular Toxoplasmosis Is Associated with Decreased Ifn-\u03b3\/Il-17a and Increased Il-6\/Il-13 Intraocular Levels. PLoS Negl Trop Dis 7:e2541. https:\/\/doi.org\/10.1371\/journal.pntd.0002541","journal-title":"PLoS Negl Trop Dis"},{"key":"578_CR24","doi-asserted-by":"publisher","first-page":"4037","DOI":"10.1128\/JCM.40.11.4037-4044.2002","volume":"40","author":"B Carme","year":"2002","unstructured":"Carme B, Bissuel F, Ajzenberg D et al (2002) Severe Acquired Toxoplasmosis in Immunocompetent Adult Patients in French Guiana. J Clin Microbiol 40:4037\u20134044. https:\/\/doi.org\/10.1128\/JCM.40.11.4037-4044.2002","journal-title":"J Clin Microbiol"},{"key":"578_CR25","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.ijpara.2015.10.005","volume":"46","author":"EK Shwab","year":"2016","unstructured":"Shwab EK, Jiang T, Pena HFJ et al (2016) The ROP18 and ROP5 gene allele types are highly predictive of virulence in mice across globally distributed strains of Toxoplasma gondii. Int J Parasitol 46:141\u2013146. https:\/\/doi.org\/10.1016\/j.ijpara.2015.10.005","journal-title":"Int J Parasitol"},{"key":"578_CR26","doi-asserted-by":"publisher","first-page":"e3182","DOI":"10.1371\/journal.pntd.0003182","volume":"8","author":"A Khan","year":"2014","unstructured":"Khan A, Ajzenberg D, Mercier A et al (2014) Geographic Separation of Domestic and Wild Strains of Toxoplasma gondii in French Guiana Correlates with a Monomorphic Version of Chromosome1a. PLoS Negl Trop Dis 8:e3182. https:\/\/doi.org\/10.1371\/journal.pntd.0003182","journal-title":"PLoS Negl Trop Dis"},{"key":"578_CR27","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1136\/bjo.2007.123661","volume":"92","author":"JG Garweg","year":"2008","unstructured":"Garweg JG, Scherrer JN, Halberstadt M (2008) Recurrence characteristics in European patients with ocular toxoplasmosis. Br J Ophthalmol 92:1253\u20131256. https:\/\/doi.org\/10.1136\/bjo.2007.123661","journal-title":"Br J Ophthalmol"},{"key":"578_CR28","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.ajo.2003.09.040","volume":"136","author":"GN Holland","year":"2003","unstructured":"Holland GN (2003) Ocular toxoplasmosis: a global reassessment. Am J Ophthalmol 136:973\u2013988. https:\/\/doi.org\/10.1016\/j.ajo.2003.09.040","journal-title":"Am J Ophthalmol"},{"key":"578_CR29","doi-asserted-by":"publisher","first-page":"xtaf002","DOI":"10.1093\/femsmc\/xtaf002","volume":"6","author":"A de-la-Torre","year":"2025","unstructured":"de-la-Torre A, Mej\u00eda-Salgado G, Eraghi AT, Pleyer U (2025) Age and ocular toxoplasmosis: a narrative review. FEMS Microbes 6:xtaf002. https:\/\/doi.org\/10.1093\/femsmc\/xtaf002","journal-title":"FEMS Microbes"},{"key":"578_CR30","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1086\/595793","volume":"199","author":"A Elbez-Rubinstein","year":"2009","unstructured":"Elbez-Rubinstein A, Ajzenberg D, Dard\u00e9 M et al (2009) Congenital Toxoplasmosis and Reinfection during Pregnancy: Case Report, Strain Characterization, Experimental Model of Reinfection, and Review. J INFECT DIS 199:280\u2013285. https:\/\/doi.org\/10.1086\/595793","journal-title":"J INFECT DIS"},{"key":"578_CR31","doi-asserted-by":"publisher","first-page":"e02280","DOI":"10.1128\/mBio.02280-14","volume":"6","author":"KDC Jensen","year":"2015","unstructured":"Jensen KDC, Camejo A, Melo MB et al (2015) Toxoplasma gondii Superinfection and Virulence during Secondary Infection Correlate with the Exact ROP5\/ROP18 Allelic Combination. mBio 6:e02280\u2013e02214. https:\/\/doi.org\/10.1128\/mBio.02280-14","journal-title":"mBio"},{"key":"578_CR32","doi-asserted-by":"publisher","first-page":"881","DOI":"10.2310\/JIM.0b013e31821b8755","volume":"59","author":"C Aranow","year":"2011","unstructured":"Aranow C (2011) Vitamin D and the immune system. J Investig Med 59:881\u2013886. https:\/\/doi.org\/10.2310\/JIM.0b013e31821b8755","journal-title":"J Investig Med"},{"key":"578_CR33","first-page":"1184","volume":"48","author":"Z Fakhrieh Kashan","year":"2019","unstructured":"Fakhrieh Kashan Z, Shojaee S, Keshavarz H et al (2019) Vitamin D Deficiency and Toxoplasma Infection. Iran J Public Health 48:1184\u20131186","journal-title":"Iran J Public Health"},{"key":"578_CR34","doi-asserted-by":"publisher","unstructured":"Tayeb FA, Salman YJ, Ameen KM (2019) The Impact of Toxoplasma gondii infection on the vitamin D3 levels among women in childbearing age in Kirkuk Province-Iraq. OJMM 09:151\u2013167. https:\/\/doi.org\/10.4236\/ojmm.2019.94015","DOI":"10.4236\/ojmm.2019.94015"},{"key":"578_CR35","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s12639-022-01556-5","volume":"47","author":"A Geraili","year":"2023","unstructured":"Geraili A, Badirzadeh A, Sadeghi M et al (2023) Toxoplasmosis and symptoms severity in patients with COVID-19 in referral centers in Northern Iran. J Parasit Dis 47:185\u2013191. https:\/\/doi.org\/10.1007\/s12639-022-01556-5","journal-title":"J Parasit Dis"},{"key":"578_CR36","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s11481-021-09997-0","volume":"16","author":"K Roe","year":"2021","unstructured":"Roe K (2021) The Symptoms and Clinical Manifestations Observed in COVID-19 Patients\/Long COVID-19 Symptoms that Parallel Toxoplasma gondii Infections. J Neuroimmune Pharmacol 16:513\u2013516. https:\/\/doi.org\/10.1007\/s11481-021-09997-0","journal-title":"J Neuroimmune Pharmacol"},{"key":"578_CR37","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1159\/000216188","volume":"16","author":"FS Dhabhar","year":"2009","unstructured":"Dhabhar FS (2009) Enhancing versus Suppressive Effects of Stress on Immune Function: Implications for Immunoprotection and Immunopathology. Neuroimmunomodulation 16:300\u2013317. https:\/\/doi.org\/10.1159\/000216188","journal-title":"Neuroimmunomodulation"},{"key":"578_CR38","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1056\/NEJM199801153380307","volume":"338","author":"BS McEwen","year":"1998","unstructured":"McEwen BS (1998) Protective and Damaging Effects of Stress Mediators. N Engl J Med 338:171\u2013179. https:\/\/doi.org\/10.1056\/NEJM199801153380307","journal-title":"N Engl J Med"},{"key":"578_CR39","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/nri1571","volume":"5","author":"R Glaser","year":"2005","unstructured":"Glaser R, Kiecolt-Glaser JK (2005) Stress-induced immune dysfunction: implications for health. Nat Rev Immunol 5:243\u2013251. https:\/\/doi.org\/10.1038\/nri1571","journal-title":"Nat Rev Immunol"},{"key":"578_CR40","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1080\/10253890701292119","volume":"10","author":"GP Chrousos","year":"2007","unstructured":"Chrousos GP, Kino T (2007) Glucocorticoid action networks and complex psychiatric and\/or somatic disorders. Stress 10:213\u2013219. https:\/\/doi.org\/10.1080\/10253890701292119","journal-title":"Stress"},{"key":"578_CR41","doi-asserted-by":"publisher","unstructured":"Glaser R, MacCallum RC, Laskowski BF et al (2001) Evidence for a shift in the Th-1 to Th-2 cytokine response associated with chronic stress and aging. J Gerontol A Biol Sci Med Sci. 56:M477\u2013M482. https:\/\/doi.org\/10.1093\/gerona\/56.8.M477","DOI":"10.1093\/gerona\/56.8.M477"},{"key":"578_CR42","doi-asserted-by":"publisher","first-page":"17312","DOI":"10.1073\/pnas.0407162101","volume":"101","author":"ES Epel","year":"2004","unstructured":"Epel ES, Blackburn EH, Lin J et al (2004) Accelerated telomere shortening in response to life stress. Proc Natl Acad Sci USA 101:17312\u201317315. https:\/\/doi.org\/10.1073\/pnas.0407162101","journal-title":"Proc Natl Acad Sci USA"},{"key":"578_CR43","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1093\/jnci\/dji401","volume":"97","author":"AN Saul","year":"2005","unstructured":"Saul AN, Oberyszyn TM, Daugherty C et al (2005) Chronic Stress and Susceptibility to Skin Cancer. JNCI: J Natl Cancer Inst 97:1760\u20131767. https:\/\/doi.org\/10.1093\/jnci\/dji401","journal-title":"JNCI: J Natl Cancer Inst"},{"key":"578_CR44","doi-asserted-by":"publisher","first-page":"e12710","DOI":"10.1111\/jsr.12710","volume":"27","author":"DA Kalmbach","year":"2018","unstructured":"Kalmbach DA, Anderson JR, Drake CL (2018) The impact of stress on sleep: Pathogenic sleep reactivity as a vulnerability to insomnia and circadian disorders. J Sleep Res 27:e12710. https:\/\/doi.org\/10.1111\/jsr.12710","journal-title":"J Sleep Res"},{"key":"578_CR45","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.biopsych.2015.05.014","volume":"80","author":"MR Irwin","year":"2016","unstructured":"Irwin MR, Olmstead R, Carroll JE (2016) Sleep Disturbance, Sleep Duration, and Inflammation: A Systematic Review and Meta-Analysis of Cohort Studies and Experimental Sleep Deprivation. Biol Psychiatry 80:40\u201352. https:\/\/doi.org\/10.1016\/j.biopsych.2015.05.014","journal-title":"Biol Psychiatry"},{"key":"578_CR46","doi-asserted-by":"publisher","first-page":"582","DOI":"10.12659\/MSM.892220","volume":"21","author":"D K\u0119cik","year":"2015","unstructured":"K\u0119cik D (2015) Do Pregnancy, Postpartum Period and Lactation Predispose to Recurrent Toxoplasmic Retinochoroiditis? Med Sci Monit 21:582\u2013584. https:\/\/doi.org\/10.12659\/MSM.892220","journal-title":"Med Sci Monit"},{"key":"578_CR47","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/S0002-9394(14)74456-3","volume":"115","author":"A Rothova","year":"1993","unstructured":"Rothova A, Meenken C, Buitenhuis HJ et al (1993) Therapy for Ocular Toxoplasmosis. Am J Ophthalmol 115:517\u2013523. https:\/\/doi.org\/10.1016\/S0002-9394(14)74456-3","journal-title":"Am J Ophthalmol"}],"container-title":["Journal of Ophthalmic Inflammation and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12348-026-00578-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12348-026-00578-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12348-026-00578-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:04:19Z","timestamp":1784073859000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12348-026-00578-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,21]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["578"],"URL":"https:\/\/doi.org\/10.1186\/s12348-026-00578-x","relation":{},"ISSN":["1869-5760"],"issn-type":[{"value":"1869-5760","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,21]]},"assertion":[{"value":"21 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics approval for this study was obtained from the local ethics committee and all participants provided informed consent prior to their inclusion in the study.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"33"}}